Publications
5102 Results
- Journal / Conference
- International Journal of Cancer, Jan 15;150(2):279-289. doi: 10.1002/ijc.33810. Epub 2021 Oct 5
- Year
- 2022
- Research Committee(s)
- Breast and Gastrointestinal
- PMID
- PMID34528705
- Study Number(s)
- CTSU/C40503, CTSU/C80405
Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens
- Journal / Conference
- Clinical Cancer Research, Jan 15;28(2):271-278
- Year
- 2022
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID34716198
- PMC
- PMC8776596
- Study Number(s)
- S1609
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
- Journal / Conference
- Oncogene Jan;41(2):260-267
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34728807
- PMC
- PMC8738154
- Study Number(s)
- CTSU/C80405
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
- Journal / Conference
- Endocrine-Related Cancer Jan 20;29(2):99-109. doi: 10.1530/ERC-21-0107
- Year
- 2022
- Research Committee(s)
- Cancer Control
- PMID
- PMID34889205
- PMC
- PMC8776589
- Study Number(s)
- SWOG-9217
Serum Markers, Obesity and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of the National Cancer Institute Jan 4;djab210. doi: 10.1093/jnci/djab210. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID34981117
- PMC
- PMC8902339
- Study Number(s)
- S1417CD
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients
- Journal / Conference
- European Urology Jan 11;S0302-2838(21)02271-5. doi: 10.1016/j.eururo.2021.12.023. Online ahead of print
- Year
- 2022
- Research Committee(s)
- Cancer Control and Prevention and Epidemiology
- PMID
- PMID35031163
- Study Number(s)
- S0000, SWOG-9217
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry
- Journal / Conference
- ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1922
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma: SWOG S1922
- Journal / Conference
- ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S2104
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors: SWOG S2104
- Journal / Conference
- American Journal of Clinical Nutrition Jan 18;nqac013. doi: 10.1093/ajcn/nqac013. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Prevention and Epidemiology
- PMID
- PMID35040869
- Study Number(s)
- S0000C
Change in Plasma Alpha-Tocopherol Associations with Attenuated Pulmonary Function Decline and with CYP4F2 Missense Variation
- Journal / Conference
- Journal of Clinical Oncology Feb 14;JCO2101766. doi: 10.1200/JCO.21.01766. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Leukemia
- PMID
- PMID35157496
- Study Number(s)
- S1318